CD19 and B-cell non-Hodgkin lymphoma: In this retrospective study we presented four patients with R/R B-cell lymphoma who received CD19 CAR T therapy and developed t-MN thereafter, three cases with MDS and one with overt acute myeloid leukemia (AML).